References
- ARAB J.P., ARRESE M., TRAUNER M., 2018 - Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annual Review of Pathology: Mechanisms of Disease 13, 321-50.
- BARVE K., 2021 - Garcinol enriched fraction from the fruit rind of Garcinia indica ameliorates atherosclerotic risk factor in diet induced hyperlipidemic C57BL/6 mice. Journal of Traditional and Complementary Medicine 11(2), 95-102.
- BASARANOGLU M., BASARANOGLU G., SABUNCU T., SENTÜRK H., 2013 - Fructose as a key player in the development of fatty liver disease. World Journal of Gastroenterology 19(8), 1166-72.
- BASUMATARY D., DAS S., BIDYARANI DEVI M., SHALINI DEVI G., SARMA P., MUKHERJEE A.K., KHAN M.R., BORAH J.C., 2024 - Garcinol enriched fraction of Garcinia morella (Gaertn.) Desr. fruit rind improves gut health and reduces the risk of nonalcoholic fatty liver disease by regulating PCK1/ACC/SREBP1/FASn pathway in a mouse model. Food Research International 197, 115285.
- BUZZETTI E., PINZANI M., TSOCHATZIS E.A., 2016 - The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: Clinical and Experimental 65(8), 1038-48.
- CAO S.S., KAUFMAN R.J., 2014 - Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxidants & Redox Signaling 21(3), 396-413.
- CHALASANI N., YOUNOSSI Z., LAVINE J.E., CHARLTON M., CUSI K., RINELLA M., HARRISON S.A., BRUNT E.M., SANYAL A.J., 2018 - The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1), 328-57.
- CHEN J-T., KOTANI K., 2016 - Astaxanthin as a Potential Protector of Liver Function: A Review. Journal of Clinical Medicine Research 8(10), 701-4.
- CHEN Z., TIAN R., SHE Z., CAI J., LI H., 2020 - Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radical Biology and Medicine 152, 116-41.
- CHEN Z., YU Y., CAI J., LI H., 2019 - Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease. Trends in Endocrinology & Metabolism 30(12), 903-14.
- CHOPRA, A.S., LORDAN, R., HORBAŃCZUK, O.K., ATANASOV, A.G., CHOPRA, I., HORBAŃCZUK, J.O., JÓŹWIK, A., (...), Arkells, N., 2022 - The current use and evolving landscape of nutraceuticals. Pharmacological Research 175, doi: 10.1016/j.phrs.2021.106001.
- CICERO A.F.G., COLLETTI A., BELLENTANI S., 2018 - Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. Nutrients 10(9), 1153.
- CROSAS-MOLIST E., FABREGAT I., 2015 - Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biology 6, 106-11.
- DE A., BHAGAT N., MEHTA M., TANEJA S., DUSEJA A., 2024 - Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD. Journal of Hepatology 80(2), e61-62.
- DIXIT V., JOSEPH KAMAL S.W., BAJRANG CHOLE P., DAYAL D., CHAUBEY K.K., PAL A.K., XAVIER J., MANJUNATH B.T., BACHHETI R.K., 2023. Functional Foods: Exploring the Health Benefits of Bioactive Compounds from Plant and Animal Sources. Journal of Food Quality 1, 5546753.
- ESLAM M., NEWSOME P.N., SARIN S.K., ANSTEE Q.M., TARGHER G., ROMERO-GOMEZ M., ZELBER-SAGI S., WAI-SUN WONG V., DUFOUR JF., SCHATTENBERG J.M., KAWAGUCHI T., ARRESE M., VALENTI L., SHIHA G., TIRIBELLI C., YKI-JÄRVINEN H., FAN JG., GRØNBÆK H., YILMAZ Y., CORTEZ-PINTO H., OLIVEIRA C.P., BEDOSSA P., ADAMS L.A., ZHENG M.H., FOUAD Y., CHAN W.K., MENDEZ-SANCHEZ N., AHN S.H., CASTERA L., BUGIANESI E., RATZIU V., GEORGE J., 2020a - A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. Journal of Hepatology 73(1), 202-9.
- ESLAM M., SANYAL A.J., GEORGE J., SANYAL A., NEUSCHWANDER-TETRI B., TIRIBELLI C., KLEINER D.E., BRUNT E., BUGIANESI E., YKI-JÄRVINEN H., GRØNBÆK H., CORTEZ-PINTO H., FAN J., VALENTI L., ABDELMALEK M., ROMERO-GOMEZ M., RINELLA M., ARRESE M., BEDOSSA P., NEWSOME PN., ANSTEE Q.M., JALAN R., BATALLER R., LOOMBA R., SOOKOIAN S., SARIN S.K., HARRISON S., KAWAGUCHI T., WONG V.W.S., RATZIU V., YILMAZ Y., YOUNOSSI Z., 2020b - MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158(7), 1999-2014.e1.
- FERRIERO R., NUSCO E., DE CEGLI R., CARISSIMO A., MANCO G., BRUNETTI-PIERRI N., 2018 - Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure. Journal of Hepatology 69(2), 325-35.
- FINER N., 2022 - Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes, Obesity and Metabolism 24 Suppl 2, 44-54.
- FLAMMENT M., KAMMOUN HL., HAINAULT I., FERRÉ P., FOUFELLE F., 2010 -Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis. Current Opinion in Lipidology 21(3), 239-46.
- FORRESTER S.J., KIKUCHI D.S., HERNANDES M.S., XU Q., GRIENDLING K.K., 2018 -Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circulation Research 122(6), 877-902.
- FRIEDMAN S.L., NEUSCHWANDER-TETRI B.A., RINELLA M., SANYAL A.J., 2018 -Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine 24(7),908-22.
- GENTILE C.L., FRYE M., PAGLIASSOTTI M.J., 2011 - Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxidants & Redox Signaling 15(2), 505-21.
- GUO X., YIN X., LIU Z., WANG J., 2022 - Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. International Journal of Molecular Sciences 23(24), 15489.
- HARRISON S.A., BEDOSSA P., GUY C.D., SCHATTENBERG J.M., LOOMBA R., TAUB R., LABRIOLA D., MOUSSA S.E., NEFF G.W., RINELLA M.E., ANSTEE Q.M., ABDELMALEK M.F., YOUNOSSI Z., BAUM S.J., FRANCQUE S., CHARLTON M.R., NEWSOME P.N., LANTHIER N., SCHIEFKE I., MANGIA A., PERICÀS J.M., PATIL R., SANYAL A.J., NOUREDDIN M., BANSAL M.B., ALKHOURI N., CASTERA L., RUDRARAJU M., RATZIU V., 2024 - A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. The New England Journal of Medicine 390(6), 497-509
- HEEREN J., SCHEJA L., 2021 - Metabolic-associated fatty liver disease and lipoprotein metabolism. Molecular Metabolism 50, 101238.
- HSU C-L., LIN Y-J., HO C-T., YEN G-C., 2012 - Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells. Food & Function 3(1), 49-57.
- HUMINIECKI L, HORBAŃCZUK J., 2018 - The functional genomic studies of resveratrol in respect to its anti-cancer effects. Biotechnology Advances Doi: 10.1016/J.Biotechadv.2018.02.011.
- JENSEN T., ABDELMALEK M.F., SULLIVAN S., NADEAU K.J., GREEN M., RONCAL C., NAKAGAWA T., KUWABARA M., SATO Y., KANG D-H., TOLAN DR., SANCHEZ-LOZADA L.G., ROSEN H.R., LANASPA M.A., DIEHL A.M., JOHNSON R.J., 2018 - Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. Journal of Hepatology 68(5), 1063-75.
- JIA Y., WU C., KIM J., KIM B., LEE S-J., 2016 - Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. The Journal of Nutritional Biochemistry 28, 9-18.
- JING Y., AI Q., LIN L., DAI J., JIA M., ZHOU D., CHE Q., WAN J., JIANG R., ZHANG L. 2014. Protective effects of garcinol in mice with lipopolysaccharide/D-galactosamine-induced apoptotic liver injury. International Immunopharmacology 19(2), 373-80
- KASPRZAK-DROZD K., NIZIŃSKI P., KASPRZAK P., KONDRACKA A., ONISZCZUK T., RUSINEK A., ONISZCZUK A., 2024 - Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International Journal of Molecular Sciences 25(7), 3746.
- KAYLAN K.B., PAUL S., 2024 - NAFLD No More: A Review of Current Guidelines in the Diagnosis and Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Current Diabetes Reports 25(1), 5.
- KIM B., FARRUGGIA C., KU C.S., PHAM TX., YANG Y., BAE M., WEGNER C.J., FARRELL N.J., HARNESS E., PARK Y-K., KOO S.I., LEE J-Y., 2017 - Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis. The Journal of Nutritional Biochemistry 43, 27-35.
- KIM M-B., LEE J., LEE J-Y., 2024 - Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components. Journal of Lipid and Atherosclerosis 13(3), 306-27.
- KOBORI M., TAKAHASHI Y., SAKURAI M., NI Y., CHEN G., NAGASHIMADA M., KANEKO S., OTA T., 2017 - Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E. International Journal of Molecular Sciences 18(3), 593.
- LEBEAUPIN C., VALLÉE D., HAZARI Y., HETZ C., CHEVET E., BAILLY-MAITRE B., 2018 - Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. Journal of Hepatology 69(4), 927-47.
- LEE K-C., WU P-S., LIN H-C., 2023 - Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clinical and Molecular Hepatology 29(1), 77-98.
- LEE P-S., TENG C-Y., KALYANAM N., HO C-T., PAN M-H., 2019 - Garcinol Reduces Obesity in High-Fat-Diet-Fed Mice by Modulating Gut Microbiota Composition. Molecular Nutrition & Food Research 63(2), e1800390.
- LI CH., LI J., JIANG F., LI Y., TZVETKOV N.T., HORBANCZUK J.O., ATANASOV A.,WANG D., 2021 - Vasculoprotective effects of ginger (Zingiber officinale Roscoe) and underlying molecular mechanisms. Food and Function 12, 1897-1913.
- LI S., TAKAHARA T., FUJINO M., FUKUHARA Y., SUGIYAMA T., LI X-K., TAKAHARA S. 2017. Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. PLoS One 12(11), 1-16
- LI Z., LIN K., WANG Y., MAO J., YIN Y., LI Z., WANG F., ZENG X., LI Q., WANG X., LI Z., MIAO R., LIN C., MAO C., 2025 - Garcinol promotes wound healing in diabetic mice by regulating inflammation and NLRP3 inflammasome-mediated pyroptosis via the PI3K/Akt/NF-κB pathway. International Immunopharmacology 151, 114352.
- LIM SH., LEE HS., LEE CH., CHOI C-I., 2021 - Pharmacological activity of garcinia indica (kokum): an updated review. Pharmaceuticals (Basel) 14(12), 1338.
- ŁAWIŃSKI M., ZADKA K., KSEPKA N., MATIN M., WYSOCKI K., KARKOCHA D., GRADOWSKA A., ATANASOV A.G., SŁODKOWSKI M., WIERZBICKA A., JÓŹWIK A., 2025 - Does resveratrol impact oxidative stress markers in patients with head and neck cancer receiving home enteral nutrition? Nutrients 17(3), 504.
- MAJEED M., MAJEED S., NAGABHUSHANAM K., LAWRENCE L., MUNDKUR L., 2020a - Novel combinatorial regimen of garcinol and curcuminoids for non-alcoholic steatohepatitis (NASH) in mice. Scientific Reports 10(1), 7440.
- MAJEED M., MAJEED S., NAGABHUSHANAM K., LAWRENCE L., MUNDKUR L., 2020b - Garcinia indica extract standardized for 20% Garcinol reduces adipogenesis and high fat diet-induced obesity in mice by alleviating endoplasmic reticulum stress. Journal of Functional Foods 67, 103863.
- MASARONE M., ROSATO V., DALLIO M., GRAVINA AG., AGLITTI A., LOGUERCIO C., FEDERICO A., PERSICO M., 2018 - Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxidative Medicine and Cellular Longevity 2018(1), 9547613.
- MATIN M., KSEPKA N., WYSOCKI K., MICKAEL M-E., PANDE A., HORBAŃCZUK JO., JÓŹWIK A., ADAMSKA O., STOLARCZYK A., IANTOVICS LB., ILIEVA Y., PENCHEV P., ATANASOV A.G., 2025. Curcumin dietary supplementation enhances serum carbohydrate-degrading enzyme activities in buffaloes. Current Research in Biotechnology 9, 100276.
- MIGNINI I., GALASSO L., PICCIRILLI G., CALVEZ V., TERMITE F., ESPOSTO G., BORRIELLO R., MIELE L., AINORA ME., GASBARRINI A., ZOCCO M.A., 2024 - Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD). Antioxidants. 13(12),1532.
- MOZOS I., STOIAN D., CARABA A., MALAINER C., HORBAŃCZUK J., ATANASOV A., 2018 - Lycopene and vascular health. Frontiers In Pharmacology 9, 521.
- MOZOS I., FLANGEA C., VLAD D.C., GUG C., MOZOS C., STOIAN D., LUCA C.T., HORBAŃCZUK J.O., HORBAŃCZUK O.K., ATANASOV A.G., 2021 - Effects of Anthocyanins on Vascular Health. Biomolecules 11, 811.
- NGUYEN-LE D., NGO-MY T., VO-MINH T., NGUYEN C-T., TRAN LT., TRAN-VAN H. 2023 - Astaxanthin prevents hepatosteatosis and hyperlipidemia but not obesity in high-fat diet fed mice. The Journal of Microbiology, Biotechnology and Food Sciences 12(5), e5950.
- NI Y., NAGASHIMADA M., ZHUGE F., ZHAN L., NAGATA N., TSUTSUI A., NAKANUMA Y., KANEKO S., OTA T., 2015 - Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Scientific Reports 5,17192.
- NISHIDA Y., BERG PC., SHAKERSAIN B., HECHT K., TAKIKAWA A., TAO R., KAKUTA Y., URAGAMI C., HASHIMOTO H., MISAWA N., MAOKA T., 2023 - Astaxanthin: Past, Present, and Future. Marine Drugs 21(10), 514.
- NOCE A., DI LAURO M., DI DANIELE F., PIETROBONI ZAITSEVA A., MARRONE G., BORBONI P., DI DANIELE N. 2021. Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome. Nutrients 13(2):630
- PANDEY B., BARAL R., KAUNDINNYAYANA A., PANTA S., 2023 - Promising hepatoprotective agents from the natural sources: a study of scientific evidence. Egyptian Liver Journal 13(1), 14.
- PIECZYNSKA M.D., Yang Y., PETRYKOWSKI S., Horbanczuk O..K, ATANASOV A.G., HORBAŃCZUK J.O., 2020 - Gut microbiota and its metabolites in atherosclerosis Development. Molecules 25(3), 594.
- PURI P., MIRSHAHI F., CHEUNG O., NATARAJAN R., MAHER JW., KELLUM J.M., SANYAL A.J., 2008 - Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134(2), 568-76.
- RADA P., GONZÁLEZ-RODRÍGUEZ Á., GARCÍA-MONZÓN C., VALVERDE Á.M., 2020 -Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death & Disease 11(9), 802
- RADICE R.P., LIMONGI A.R., VIVIANO E., PADULA MC., MARTELLI G., BERMANO G., 2021 - Effects of astaxanthin in animal models of obesity-associated diseases: A systematic review and meta-analysis. Free Radical Biology and Medicine 171, 156-68.
- RANVEER R., SAHOO A. 2017. Bioactive Constituents of Kokum and its Potential Health Benefits. Nutrition and Food Toxicology 1(6):236-44
- RINELLA M.E., LAZARUS J.V., RATZIU V., FRANCQUE S.M., SANYAL A.J., KANWAL F., ROMERO D., ABDELMALEK M.F., ANSTEE Q.M., ARAB J.P., ARRESE M., BATALLER R., BEUERS U., BOURSIER J., BUGIANESI E., BYRNE C.D., CASTRO NARRO G.E., CHOWDHURY A., CORTEZ-PINTO H., CRYER D.R., CUSI K., EL-KASSAS M., KLEIN S., ESKRIDGE W., FAN J., GAWRIEH S., GUY C.D., HARRISON S.A., KIM S.U., KOOT B.G., KORENJAK M., KOWDLEY K.V., LACAILLE F., LOOMBA R., MITCHELL-THAIN R., MORGAN T.R., POWELL E.E., RODEN M., ROMERO-GÓMEZ M., SILVA M., SINGH S.P., SOOKOIAN S.C., SPEARMAN C.W., TINIAKOS D., VALENTI L., VOS M.B., WONG V.W., XANTHAKOS S., YILMAZ Y., YOUNOSSI Z., HOBBS A., VILLOTA-RIVAS M., NEWSOME P.N., 2023a - A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78(6), 1966-86.
- RINELLA M.E., NEUSCHWANDER-TETRI B.A., SIDDIQUI M.S., ABDELMALEK M.F., CALDWELL S., BARB D., KLEINER DE., LOOMBA R., 2023b - AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5), 1797-1835.
- RIZZO M., COLLETTI A., PENSON P.E., KATSIKI N., MIKHAILIDIS D.P., TOTH P.P., GOUNI-BERTHOLD I., MANCINI J., MARAIS D., MORIARTY P., RUSCICA M., SAHEBKAR A., VINEREANU D., CICERO A.F.G., BANACH M., 2023 - Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research 189, 106679.
- RONG L., ZOU J., RAN W., QI X., CHEN Y., CUI H., GUO J., 2022 - Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Frontiers in Endocrinology (Lausanne) 13, 1087260.
- SAMUEL V.T., SHULMAN G.I., 2018 - Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metabolism 27(1), 22-41.
- SCHOBERT R., BIERSACK B. 2019. Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent Developments. Chemistry & Biodiversity 16(9):e1900366
- SILVA FIGUEIREDO P., INADA A.C., RIBEIRO FERNANDES M., GRANJA ARAKAKI D., FREITAS K DE C., AVELLANEDA GUIMARÃES R DE C., ARAGÃO DO NASCIMENTO V., AIKO HIANE P., 2018 - An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. Molecules 23(4), 877.
- SVOBODOVÁ G., HORNÍ M., VELECKÁ E., BOUŠOVÁ I., 2025, Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review. Archives of Toxicology 99(1), 1-22.
- TEWARI D., MOCAN A., PARVANOV E.D., SAH A.N., NABAVI S.N., HUMINIECKI L., MA., Z.F., LEE Y.Y., HORBAŃCZUK J.O., ATANASOV A.G., 2017b - Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from acanthaceae, euphorbiaceae, asteraceae, combretaceae, and fabaceae families. Frontiers in Pharmacology Doi: 10.3389/Fphar.2017.00519.
- SYED-ABDUL M.M.,2024. Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). Metabolites 14(1), 12.
- VAN DER VLIET A., JANSSEN-HEININGER YMW., ANATHY V., 2018 - Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling. Molecular Aspects of Medicine 63, 59-69.
- WANG M., XU W., YU J., LIU Y., MA H., JI C., ZHANG C., XUE J., LI R., CUI H., 2022. -Astaxanthin From Haematococcus pluvialis Prevents High-Fat Diet-Induced Hepatic Steatosis and Oxidative Stress in Mice by Gut-Liver Axis Modulating Properties. Frontiers in Nutrition 9, 840648.
- WANG X., FENG J., WU R., TAN J., HUANG Q., PHANG Y., ZHANG L., FU W., XU H., ZHENG C., 2023 - Garcinol and its analogues: Synthesis, cytotoxic activity and mechanistic investigation. Bioorganic Chemistry 133, 106389.
- WANG D., ÖZEN C., ABU-REIDAH I.M., CHGURUPATI S., PATRA J.K., HORBAŃCZUK J.O., JÓŹWIK A., TZVETKOV N.T., UHRIN P., ATANASOV A.G., 2018 - Vasculoprotective effects of pomegranate (Punica granatum L.). Frontiers in Pharmacology 9:544 Doi: 10.3389/Fphar.2018.00544.
- WANG D., ZHANG L., HUANG J., HIMABINDU K., TEWARI D., HORBAŃCZUK J.O., XU S., CHEN Z., ATANASOV A.G., 2020 - Cardiovascular protective effect of black pepper (Piper nigrum L.) and its major bioactive constituent piperine. Trends in Food Science & Technology https://doi.org/10.1016/j.tifs.2020.11.024.
- WU L., MO W., FENG J., LI J., YU Q., LI S., ZHANG J., CHEN K., JI J., DAI W., WU J., XU X., MAO Y., GUO C., 2020 - Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway. British Journal of Pharmacology 177(16), 3760-77.
- XU J., RONG S., GAO H., CHEN C., YANG W., DENG Q., HUANG Q., XIAO L., HUANG F., 2017 - A Combination of Flaxseed Oil and Astaxanthin Improves Hepatic Lipid Accumulation and Reduces Oxidative Stress in High Fat-Diet Fed Rats. Nutrients 9(3), 271.
- YANG M., KIMCHI E.T., STAVELEY-O’CARROLL K.F., LI G., 2021 - Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity. International Journal of Molecular Sciences 22(20), 11037.
- YANG Y., PHAM T.X., WEGNER C.J., KIM B., KU C.S., PARK Y-K., LEE J-Y., 2014 -Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. British Journal of Nutrition 112(11), 1797-1804.
- YEUNG A.W.K., AGGARWA, B., BARRECA D., BATTINO M., BELWAL T., HORBAŃCZUK O., BERINDAN-NEAGOE I., BISHAYEE A., DAGLIA M., DEVKOTA H., ECHEVERRÍA J., ELDEMERDASH A., ORHAN I., GODFREY K., GUPTA V., HORBAŃCZUK J., MODLIŃSKI J., HUBER L., HUMINIECKI L., JÓŹWIK A., MARCHEWKA J., MILLER M., MOCAN A., MOZOS I., NABAVI S., NABAVI S., PIECZYNSKA M., PITTALÀ V., RENGASAMY K., SILVA A., SHERIDAN H., STANKIEWICZ A., STRZAŁKOWSKA N., SUREDA A., TEWARI D., WEISSIG V., ZENGIN G., ATANASOV A., 2018 - Dietary natural products and their potential to influence health and disease including animal model studies. Animal Science Papers and Reports 36, 345-358.
- YEUNG A.W.K., AGGARWAL B.B., ORHAN I.E., HORBAŃCZUK O.K., BARRECA D., BATTINO M., BELWAL T., BISHAYEE A., DAGLIA M., DEVKOTA H. P., ECHEVERRÍA J., EL-DEMERDASH A., BALACHEVA A., GEORGIEVA M., GODFREY K., GUPTA V., HORBAŃCZUK J.O., HUMINIECKI L., JÓŹWIK A., STRZAŁKOWSKA N., MOCAN A., MOZOS I., NABAVI S.M., PAJPANOVA T., PITTALA V., FEDER-KUBIS J., SAMPINO S., SILVA A. S., SHERIDAN H., SUREDA A., TEWARI D., WANG D., WEISSIG V., YANG Y., ZENGIN G., SHANKER K., MOOSAVI M.A., SHAH M.A., KOZUHAROVA E., ALRIMAWI F., DURAZZO A., LUCARINI M., SOUTO E. B., SANTINI A., MALAINER C., DJILIANOV D., TANCHEVA L. P., LI, H.B., GAN R.Y., TZVETKOV N.T., ATANASOV A.G., 2019 - Resveratrol, a popular dietary supplement for human and animal health: Quantitative research literature analysis - a review. Animal Science Papers and Reports 37, 103-118.
- YEUNG, A. W. K., CHOUDHARY, N., TEWARI, D., EL-DEMERDASH, A., HORBANCZUK, O. K., DAS, N., PIRGOZLIEV, V., LUCARINI, M., DURAZZO, A., SOUTO, E. B., SANTINI, A., DEVKOTA, H. P., UDDIN, M. S., ECHEVERRIA, J., WANG, D., GAN, R. Y., BRNCIC, M., KALFIN, R. E., TZVETKOV, N. T., JOZWIK, A., SOLKA, M., STRZALKOWSKA, N., HORBANCZUK, J. O., ATANASOV, A. G., 2021a - Quercetin: total-scale literature landscape analysis of a valuable nutraceutical with numerous potential applications in the promotion of human and animal health–a review. Animal Science Papers and Reports 39, 199-212.
- YEUNG A.W.K., CHOUDHARY N., TEWARI D., EL-DEMERDASH A., TOMCZYK M., DAS N., PIRGOZLIEV V., LUCARINI M., DURAZZO A., SOUTO E.B., SANTINI A., DEVKOTA H.P., UDDIN M.S., ECHEVERRÍA J., WANG D., GAN R-Y., BRNČIĆ M., KALFIN R.E., DE R., CENANOVIC M., SAI C.S., KAPOOR B., KIRILOV K., TZVETKOV N.T., BELAKOVA B., UHRIN P., JÓŹWIK A., HORBANCZUK O.K., STRZAŁKOWSKA N., KOSZARSKA M., CHARUTA A., HORBAŃCZUK J.O., ATANASOV A.G., 2022 – Lycopene: total-scale literature landscape analysis of a valuable nutraceutical with numerous potential applications in the promotion of human and animal health . Animal Science Papers and Reports 40,2, 119-134.
- YEUNG A.,KSEPKA N.,MATIN M.,WANG D.,SOUTO E.,STOYANOV J.,ECHEVERRÍA J.,TEWARI D.,HORBANCZUK J.,LUCARINI M.,DURAZZO A.,MARCHEWKA J.,PIRGOZLIEV V.,GAN R.,TZVETKOV N.,WYSOCKI K.,MATIN F.,LITVINOVA O.,BISHAYEE A.,DEVKOTA H.,EL-DEMERDASH A.,BRNČIĆ M.,SANTINI A.,HORBAŃCZUK O.,MICKAEL M.,ŁAWINSKI M.,DAS N.,SIDDIQUEA B.,HRG D. AND ATANASOV A.G., 2023 - Dietary factors in nonalcoholic fatty liver disease: impacts on human and animal health - a review. Animal Science Papers and Reports 41, 3, 179-194.
- YEUNG A.W.K., ORHAN I.E., AGGARWAL B.B., BATTINO, M., BELWAL T., BISHAYEE A., DAGLIA M., DEVKOTA H.P., EL-DEMERDASH A., BALACHEVA A.A., GEORGIEVA M.G., GUPTA V.K., HORBAŃCZUK J.O., JOZWIK A., MOZOS I., NABAVI S.M., PITTALÀ V., FEDER-KUBIS J., SANCHES SILVA A., SHERIDAN H., SUREDA A., WANG D., WEISSIG V., YANG Y., ZENGIN G., SHANKER K., MOOSAVI M.A., SHAH M.A., AL-RIMAWI F., DURAZZO A., LUCARINI M., SOUTO E. B., SANTINI A., DJILIANOV D., DAS N., SKOTTI E., WIECZOREK A., LYSEK-GLADYSINSKA M.W., MICHALCZUK M., HORBAŃCZUK O.K., TZVETKOV N.T., ATANASOV A.G., 2020a - Berberine, a popular dietary supplement for human and animal health: Quantitative research literature analysis–a review. Animal Science Papers and Reports 38, 5-19.
- YEUNG A.W.K., SOLKA M., JÓŻWIK A., KSEPKA N., MATIN M., WANG D., ZIELIŃSKA A., MOHANASUNDARAM A.S., VEJUX A., ZARROUK A., TEWARI D., HORBAŃCZUK J.O., LUCARINI M., DURAZZO A., GHAZAIEL I., MICHALCZUK M., REZIG L., T. TZVETKOV N., MATIN F.B., LIZARD G., BISHAYEE A., DEVKOTA H.P., EL-DEMERDASH A., BRNCIC M., SANTINI A., MICKAEL M.E., HORBAŃCZUK O., CHARUTA A., SZAFRAŃSKA K., MAŁACHOWSKA E., WIECZOREK M., SIDDIQUEA B.N., HRG D., FRAZINI S., ROSSI L., K. SINGA R., WIECZOREK A., ŁYSEK-GLADYSIŃSKA M., SAI CHANDRAGIRI S., ADAMSKA O., STOLARCZYK A., KLUSEK J., SZYMAŃSKA-CZERWIŃSKA M., NIEMCZUK K., HEJNA M., SZTANDARSKI P., JASZCZUK A., MICHNOWSKA H., TOMASIK C., ZIMA-KULISIEWICZ B., MARCHEWKA J., ŁAWIŃSKI M., ATANASOV A.G. 2024 - Anthocyanins-dietary natural products with a variety of bioactivities for the promotion of human and animal health. Animal Science Papers and Reports. 42(1), 5-33.
- YEUNG A.W.K., TZVETKOV N.T., EL-DEMERDASH A., HORBANCZUK O.K., DAS N., PIRGOZLIEV V., LUCARINI M., DURAZZO A., SOUTO E.B., SANTINI A., DEVKOTA H.P., UDDIN M., ECHEVERRÍA J., WANG D., GAN R.Y., BRNČIĆ M., KALFIN R., TANCHEVA L.P., TEWARI D., BERINDAN-NEAGOE I., SAMPINO S., STRZAŁKOWSKA N., MARCHEWKA J., JOZWIK A., HORBANCZUK J.O., ATANASOV A. G., 2021b - Apple polyphenols in human and animal health. Animal Science Papers and Reports 39, 105-118
- YEUNG A.W.K., TZVETKOV N.T., DURAZZO A., LUCARINI M., SOUTO E.B., SANTINI A., GAN R.-Y., JOZWIK A., GRZYBEK W., HORBAŃCZUK J.O., MOCAN A., ECHEVERRÍA J., WANG D., ATANASOV A.G., 2020b - Natural products in diabetes research: quantitative literature analysis. Natural Product Research doi: 10.1080/14786419.2020.1821019. PMID: 33025819,
- YU S., LI C., JI G., ZHANG L., 2021 - The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. Frontiers in Pharmacology 12, 783393.